JoannaOsmanska

@EmiratesSupport @emirates it's been over 72 hours since I sent DM requesting assistance. Can you please reply

@EmiratesSupport @Xevww Hello, can you please reply to my DM I sent 2 days ago

@Xevww Can you please share your booking reference, full name and email address and we’ll get back to you as soon as we can - Faisal

Due to multiple regional airspace closures, Emirates has temporarily suspended all operations to and from Dubai, up until 1500hrs UAE time on Monday, 2 March. If you are booked to travel before or on 5 March, your options are: ✈️Rebook on an alternate flight. You can rebook on another flight to your intended destination up to 20 days from your original date of travel. If you booked your flight with a travel agent, please contact them. If you booked with us directly, contact us at emirat.es/support. 🎫 ⁠Request for refund. You can request for a refund of your ticket by completing the refund form at emirat.es/refund if you booked with us directly. If you booked your flights with a travel agent, please contact them. We urge all customers to check emirat.es/flightstatus before proceeding to the airport. Customers impacted by flight cancellations must contact their travel agency for rebooking. If booked directly with Emirates, please contact us at emirat.es/support. Customers are requested to ensure their contact details are correct by visiting emirat.es/managebooking to receive updates. We are actively monitoring the situation and engaging with relevant authorities. We apologise to customers affected by disruptions for any inconvenience caused. The safety and security of our passengers and crew remain our highest priority.

@EmiratesSupport I sent you DM 2 days ago, can you please reply

@markcpetrie20 @UoGHeartFailure

Delighted to announce that recruitment for the SUBCUT-HF II trial is now complete! Can SC furosemide offer a new treatment paradigm in AHF? Huge thanks to the HF and research teams, and to all patients and families for their vital contributions 💙 #HeartFailure #SUBCUTHF

FDA approves subcutaneous diuretic treatment for heart failure-related edema The U.S. Food and Drug Administration (FDA)has approved another new treatment option for heart-failure related edema @hfcollaboratory @mvaduganathan @SJGreene_md @gcfmd @BiykemB @DrMarthaGulati @dranulala @ShelleyZieroth cardiovascularbusiness.com/topics/clinica…

🗞️ Impact of genotype–phenotype associations on prognosis in #DilatedCardiomyopathy @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd bit.ly/4nuVZBN

🔴 Current Evidence on Tricuspid Regurgitation Interventions in Heart Failure @JACCJournals #Cardiology #cardioEd

Truncating LMNA variants lead to worse arrhythmic outcomes regardless of position, whereas missense variants in the tail domain, particularly in exons 7 to 12, are associated with better cardiac outcomes. ja.ma/3TYETzn

1 year data on aficamten in the FOREST HCM trial are now published in JACC Journals pubmed.ncbi.nlm.nih.gov/40540987/ #CardioTwitter

Join us tomorrow for the #HFA_ESC webinar: "Heart Failure in the Community" 📌 3 June 2025 | 18.00-19.00 CET 🎙️Faculty: @ARakisheva, @Kieranfdocherty, @m4ggiesimpson, @KlausKWitte 🔗 Register now: esc365.escardio.org/event/1974 @escardio

@m4ggiesimpson @markcpetrie20 @Kieranfdocherty @carolinecoats @ScotCardio @UoGHeartFailure @HFA_President @ProfDConnelly @BSHeartFailure @UofGlasgow @hvanspall Thanks Maggie!

Massive congratulations to this wee belter Dr @jo_osmanska on passing her viva yesterday! 🥳 I’ve had the pleasure of knowing Joanna since she was a medical student & she’s always stood out as a brilliant Dr & an absolute🌟with patients A great colleague with a huge future ahead in #heartfailure

Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction in EHJ. doi.org/10.1093/eurhea… @ESCardio @ESC_Journals #age #5UDMI @johnwmcevoy

🚨 New HFA/ESC consensus statement! 🚨 Clinical management & therapy optimization for HFrEF patients with low BP—practical guidance for safer, more effective treatment. 📄👇 #HeartFailure ow.ly/IzyB50Va9rJ @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @HSkouri @EJHFEiC #EJHF

📌Standardized Definitions of Changes in Kidney Function in Trials of #HeartFailure: @JACCJournals Expert Panel From the #HFARC #CardioRenal #ClinicalTrials #HF #CKD

Torsemide is proposed to have clinically important pharmacokinetic and pharmacodynamic advantages over furosemide. This study found no meaningful pharmacokinetic/pharmacodynamic advantages for torsemide versus furosemide. bit.ly/JASN0481 @ClevelandClinic @CleClinicMD @fperrywilson @dhekidney

🗞️ SUGAR-DM-HF #CMR estimated PCWP & congestion markers, and effect of #empagliflozin in #HFrEF with dysglycaemia @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd @HFA_President bit.ly/3C55VQt

EMPRESS-MI: Empagliflozin vs placebo, n=105 w/ LVSD (mean LVEF 34.8%) post-AMI (24wks): ↔️LVESVI, LVEDVI, LVEF, LAVI, LVMI ↔️NT-proBNP, hs-TnI ↗️Hct ↘️urate, weight 🔗 doi.org/10.1002/ejhf.3… @CarberryJaclyn @Kieranfdocherty @markcpetrie20 @ColinBerryMD @UoGHeartFailure @UofGSCMH

Final clap for #CVCT2024 ! Thank you for 3 days of deep scientific discussions, inspiration and friendship ! Now, time for action ! #clinicaltrials #movingforward

Cardiovascular trials still under-represent diverse groups relative to population disease distribution. In @NatureMedicine, @OtavioBerwanger, @hvanspall, and @FaiezZANNAD share insights on making clinical trials in this field more inclusive. Read more: buff.ly/48kV40B